pre-update Archives

Press Coverage

全新 FDA 指南 Project Optimus 可能如何影响肿瘤学临床试验和药物研究计划的未来

Julie Bullock, VP, global head of clinical pharmacology and translational medicine at Certara, discusses the…

Certara2021 年 8 月 16 日

Blog

Gene Therapy Based Precision Medicine Therapeutics: Clinical Pharmacology & Translational Science Considerations

The era of gene therapy may have started a couple of decades ago, but approvals…

Certara2021 年 8 月 13 日

网络研讨会点播

生物制剂的临床药理计划是怎样的？

Monoclonal antibodies are now widely used in the treatment of several diseases, providing effective and…

Certara2021 年 8 月 6 日

Blog

价值沟通制胜之道：导言

Drawn from the experiences of the BaseCase Consulting Team, this is the introduction to ‘Succeeding…

Certara2021 年 8 月 5 日

Publication

应用定量系统药理学（QSP）指导 COVID-19 疫苗最佳剂量方案

Optimal use and distribution of coronavirus disease 2019 (COVID-19) vaccines involves adjustments of dosing. Due…

Certara2021 年 7 月 31 日

On-Demand Webinar

PBPK Modeling of Tizanidine Systemic Exposure by CYP1A2 Modulation: Impact of DDIs & Smoking

This webinar was presented on 2021 年 6 月 30 日 by David R. Taft, Ph.D. Professor, Pharmaceutics,…

Certara2021 年 7 月 26 日

Blog

Why You Should Participate in the Voluntary FDA Oncology Center of Excellence Assessment Aid Program

In 2018, the FDA’s Oncology Center of Excellence developed an Assessment Aid document to help…

Certara2021 年 7 月 21 日

视频

What is BaseCase?

Developing interactive and easy-to-use stakeholder engagement content market access, medical affairs, and sales field teams…

Certara2021 年 7 月 20 日

On-Demand Webinar

开源建模工具：火上浇油 vs. 平息争论

The paper “Opening a Debate on Open-Source Modelling Tools: Pouring Fuel on Fire vs. Extinguishing…

Certara2021 年 7 月 15 日

Blog

确保抗体-药物偶联物开发最大概率获得成功的关键考虑事项

Antibody drug conjugates (ADC) are a unique way to obliterate tumor cells and represent an…

Certara2021 年 7 月 8 日

pre-update

全新 FDA 指南 Project Optimus 可能如何影响肿瘤学临床试验和药物研究计划的未来

Gene Therapy Based Precision Medicine Therapeutics: Clinical Pharmacology & Translational Science Considerations

生物制剂的临床药理计划是怎样的？

价值沟通制胜之道：导言

应用定量系统药理学（QSP）指导 COVID-19 疫苗最佳剂量方案

PBPK Modeling of Tizanidine Systemic Exposure by CYP1A2 Modulation: Impact of DDIs & Smoking

Why You Should Participate in the Voluntary FDA Oncology Center of Excellence Assessment Aid Program

What is BaseCase?

开源建模工具：火上浇油 vs. 平息争论

确保抗体-药物偶联物开发最大概率获得成功的关键考虑事项

订阅时事通讯

快捷链接

解决方案

联系我们